Table of Contents
March/April 2020; Volume 74,Issue 2
Pinato, Odra
- You have accessInvestigating the Effects of the Chemical Composition on Glass Corrosion: A Case Study for Type I VialsSerena Panighello and Odra PinatoPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 185-200; DOI: https://doi.org/10.5731/pdajpst.2019.010066
Ramnarine, Emma
- You have accessManaging Excipient Supplier Name and Address Changes in the Pharmaceutical Quality SystemRichard Rolke, Emma Ramnarine, Anders Vinther and Anil SawantPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 286-288; DOI: https://doi.org/10.5731/pdajpst.2019.011239
Reber, Dona
- You have accessRisk Assessment Approach to Microbiological Controls of Cell TherapiesTony Cundell, Scott Drummond, Irving Ford, Dona Reber and Donald Singer; members of the Pharmaceutical Microbiology Expert Discussion GroupPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 229-248; DOI: https://doi.org/10.5731/pdajpst.2019.010546
Rodriguez, Roberto
- You have accessControl Strategy Approach for a Well-Characterized Vaccine Drug ProductParag Kolhe, Khurram Sunasara, Lavinia Lewis, Michele Bailey Piatchek, Roberto Rodriguez and Katherine Arch-DouglasPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 213-228; DOI: https://doi.org/10.5731/pdajpst.2018.009415
Rolke, Richard
- You have accessManaging Excipient Supplier Name and Address Changes in the Pharmaceutical Quality SystemRichard Rolke, Emma Ramnarine, Anders Vinther and Anil SawantPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 286-288; DOI: https://doi.org/10.5731/pdajpst.2019.011239
Sawant, Anil
- You have accessManaging Excipient Supplier Name and Address Changes in the Pharmaceutical Quality SystemRichard Rolke, Emma Ramnarine, Anders Vinther and Anil SawantPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 286-288; DOI: https://doi.org/10.5731/pdajpst.2019.011239
Shaw, David
- You have accessAdvancing Biologics Development Programs with Legacy Cell Lines: Advantages and Limitations of Genetic Testing for Addressing Clonality Concerns Prior to Availability of Late Stage Process and Product Consistency DataPaul Wu, Taymar Hartman, Louise Almond, Jennitte Stevens, John Thrift, Juhi Ojha, Christina Alves, David Shaw, Michael W. Laird, Robyn Emmins, Yuan Zhu, Ren Liu, Zhimei Du, Rolf Koehler, Thomas Jostock, Karin Anderson, Chris Campbell and Howard ClarkePDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 264-274; DOI: https://doi.org/10.5731/pdajpst.2018.009316
Singer, Donald
- You have accessRisk Assessment Approach to Microbiological Controls of Cell TherapiesTony Cundell, Scott Drummond, Irving Ford, Dona Reber and Donald Singer; members of the Pharmaceutical Microbiology Expert Discussion GroupPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 229-248; DOI: https://doi.org/10.5731/pdajpst.2019.010546
Stevens, Jennitte
- You have accessAdvancing Biologics Development Programs with Legacy Cell Lines: Advantages and Limitations of Genetic Testing for Addressing Clonality Concerns Prior to Availability of Late Stage Process and Product Consistency DataPaul Wu, Taymar Hartman, Louise Almond, Jennitte Stevens, John Thrift, Juhi Ojha, Christina Alves, David Shaw, Michael W. Laird, Robyn Emmins, Yuan Zhu, Ren Liu, Zhimei Du, Rolf Koehler, Thomas Jostock, Karin Anderson, Chris Campbell and Howard ClarkePDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 264-274; DOI: https://doi.org/10.5731/pdajpst.2018.009316
Sunasara, Khurram
- You have accessControl Strategy Approach for a Well-Characterized Vaccine Drug ProductParag Kolhe, Khurram Sunasara, Lavinia Lewis, Michele Bailey Piatchek, Roberto Rodriguez and Katherine Arch-DouglasPDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 213-228; DOI: https://doi.org/10.5731/pdajpst.2018.009415
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 2
March/April 2020
